ALS TDI & Corsalex: Driving Innovation in ALS & FTD Treatments

In this upcoming Town Hall, ALS TDI and Corsalex will discuss their collaboration to advance the discovery and development of effective treatments for ALS and FTD caused by C9orf72 mutations. This scientific discussion may be of particular interest to industry professionals and academic researchers, but anyone in the community is welcome to attend. 

Corsalex will also share the details of the inaugural Corsalex Postdoctoral Fellowship Program which aims to support promising early-career scientists who wish to continue research in the field of C9orf72 ALS/FTD.